246 related articles for article (PubMed ID: 20796291)
21. Arsenic trioxide induces accumulation of cytotoxic levels of ceramide in acute promyelocytic leukemia and adult T-cell leukemia/lymphoma cells through de novo ceramide synthesis and inhibition of glucosylceramide synthase activity.
Dbaibo GS; Kfoury Y; Darwiche N; Panjarian S; Kozhaya L; Nasr R; Abdallah M; Hermine O; El-Sabban M; de Thé H; Bazarbachi A
Haematologica; 2007 Jun; 92(6):753-62. PubMed ID: 17550847
[TBL] [Abstract][Full Text] [Related]
22. The synergistic antitumor activity of arsenic trioxide and vitamin K2 in HL-60 cells involves increased ROS generation and regulation of the ROS-dependent MAPK signaling pathway.
Qu H; Tong D; Zhang Y; Kang K; Zhang Y; Chen L; Ren L
Pharmazie; 2013 Oct; 68(10):839-45. PubMed ID: 24273890
[TBL] [Abstract][Full Text] [Related]
23. ANXA1 silencing increases the sensitivity of cancer cells to low-concentration arsenic trioxide treatment by inhibiting ERK MAPK activation.
Zhang X; Li X; Li X; Zheng L; Lei L
Tumori; 2015; 101(4):360-7. PubMed ID: 25983101
[TBL] [Abstract][Full Text] [Related]
24. [Potentiation of arsenic trioxide-induced apoptosis by retinoic acid in retinoic acid sensitive and resistant HL-60 myeloid leukemia cells].
Huang X
Chin Med J (Engl); 2000 Jun; 113(6):498-501. PubMed ID: 11775865
[TBL] [Abstract][Full Text] [Related]
25. BIBR 1532 increases arsenic trioxide-mediated apoptosis in acute promyelocytic leukemia cells: therapeutic potential for APL.
Bashash D; Ghaffari SH; Zaker F; Kazerani M; Hezave K; Hassani S; Rostami M; Alimoghaddam K; Ghavamzadeh A
Anticancer Agents Med Chem; 2013 Sep; 13(7):1115-25. PubMed ID: 23293885
[TBL] [Abstract][Full Text] [Related]
26. BIMEL is a key effector molecule in oxidative stress-mediated apoptosis in acute myeloid leukemia cells when combined with arsenic trioxide and buthionine sulfoximine.
Tanaka Y; Komatsu T; Shigemi H; Yamauchi T; Fujii Y
BMC Cancer; 2014 Jan; 14():27. PubMed ID: 24428916
[TBL] [Abstract][Full Text] [Related]
27. Molecular targets of arsenic trioxide in malignant cells.
Miller WH
Oncologist; 2002; 7 Suppl 1():14-9. PubMed ID: 11961205
[TBL] [Abstract][Full Text] [Related]
28. PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia.
Sternsdorf T; Puccetti E; Jensen K; Hoelzer D; Will H; Ottmann OG; Ruthardt M
Mol Cell Biol; 1999 Jul; 19(7):5170-8. PubMed ID: 10373566
[TBL] [Abstract][Full Text] [Related]
29. In-vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (Comet) assays.
Yedjou CG; Tchounwou PB
Mol Cell Biochem; 2007 Jul; 301(1-2):123-30. PubMed ID: 17216127
[TBL] [Abstract][Full Text] [Related]
30. ATR, PML, and CHK2 play a role in arsenic trioxide-induced apoptosis.
Joe Y; Jeong JH; Yang S; Kang H; Motoyama N; Pandolfi PP; Chung JH; Kim MK
J Biol Chem; 2006 Sep; 281(39):28764-71. PubMed ID: 16891316
[TBL] [Abstract][Full Text] [Related]
31. Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.
Lengfelder E; Hofmann WK; Nowak D
Leukemia; 2012 Mar; 26(3):433-42. PubMed ID: 21904379
[TBL] [Abstract][Full Text] [Related]
32. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells.
Liang H; Li X; Wang L; Yu S; Xu Z; Gu Y; Pan Z; Li T; Hu M; Cui H; Liu X; Zhang Y; Xu C; Guo R; Lu Y; Yang B; Shan H
Cell Physiol Biochem; 2013; 32(6):1818-29. PubMed ID: 24356076
[TBL] [Abstract][Full Text] [Related]
33. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Shen L; Zhang G; Lou Z; Xu G; Zhang G
BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
[TBL] [Abstract][Full Text] [Related]
34. The organic arsenic derivative GMZ27 induces PML-RARα-independent apoptosis in myeloid leukemia cells.
Cheng X; Quintás-Cardama A; Golemovic M; Zingaro R; Gao MZ; Freireich EJ; Andreeff M; Kantarjian HM; Verstovsek S
Anticancer Res; 2012 Jul; 32(7):2871-80. PubMed ID: 22753750
[TBL] [Abstract][Full Text] [Related]
35. Arsenic-induced apoptosis in malignant cells in vitro.
Akao Y; Yamada H; Nakagawa Y
Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
[TBL] [Abstract][Full Text] [Related]
36. Transcriptomic analysis of the PI3K/Akt signaling pathway reveals the dual role of the c-Jun oncogene in cytotoxicity and the development of resistance in HL-60 leukemia cells in response to arsenic trioxide.
Roszak J; Smok-Pieniążek A; Stępnik M
Adv Clin Exp Med; 2017 Dec; 26(9):1335-1342. PubMed ID: 29442453
[TBL] [Abstract][Full Text] [Related]
37. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
Ramos AM; Aller P
Biochem Pharmacol; 2008 May; 75(10):1912-23. PubMed ID: 18359480
[TBL] [Abstract][Full Text] [Related]
38. Carnosic Acid-combined Arsenic Trioxide Antileukaemia Cells in the Establishment of NB4/SCID Mouse Model.
Hao L; Ran W; Xiang-Xin L; Lu-Qun W; Xiao-Ning Y
Basic Clin Pharmacol Toxicol; 2016 Sep; 119(3):259-66. PubMed ID: 26998898
[TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells.
Shao W; Fanelli M; Ferrara FF; Riccioni R; Rosenauer A; Davison K; Lamph WW; Waxman S; Pelicci PG; Lo Coco F; Avvisati G; Testa U; Peschle C; Gambacorti-Passerini C; Nervi C; Miller WH
J Natl Cancer Inst; 1998 Jan; 90(2):124-33. PubMed ID: 9450572
[TBL] [Abstract][Full Text] [Related]
40. Arsenic trioxide and radiation enhance apoptotic effects in HL-60 cells through increased ROS generation and regulation of JNK and p38 MAPK signaling pathways.
Ho SY; Wu WJ; Chiu HW; Chen YA; Ho YS; Guo HR; Wang YJ
Chem Biol Interact; 2011 Sep; 193(2):162-71. PubMed ID: 21741957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
